Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SCA | Ann: Adoption of Modified Constitutions | 04/04/24 | 0 | 88 | |||
|
|||||||
SCA | Ann: 2023 SGT1, SGT2 and SGT3 Annual Financial Reports | 21/03/24 | 0 | 129 | |||
|
|||||||
SCA | Ann: SCG Full Year Announcement and Results Presentation | 21/02/24 | 0 | 134 | |||
|
|||||||
SCA | Ann: SCG Appendix 4E and 2023 Annual Financial Report | 21/02/24 | 0 | 111 | |||
|
|||||||
SCA | Ann: SCG Completed tender offer and introduction of DRP | 05/12/23 | 0 | 126 | |||
|
|||||||
SCA | Ann: 3rd Quarter Operational Update | 09/11/23 | 0 | 96 | |||
|
|||||||
SCA | Ann: SCG Fund Payment Notices | 22/08/23 | 0 | 143 | |||
|
|||||||
SCA | Ann: 2023 SGT1, SGT2 and SGT3 Half-Year Financial Reports | 22/08/23 | 0 | 102 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |